论文部分内容阅读
高脂血症,是高胆固醇血症和高甘油三酯血症的统称,是指当血脂浓度超“参考值”高限时的病理状态。此时,病人没有任何临床症状,常以心脑及外周血管动脉硬化性疾病为结局,后果严重,常被称为“沉默的杀手”。国内高脂血症的建议标准是:总胆固醇(TC)≥5.76mmol/L(220mg/dl),低密度脂蛋白胆固醇(LDL-C)≥3.64mmol/L(140 mg/dl),高密度脂蛋白胆固醇(HDL)≤1.04mmol/L (40 mg/dl),甘油三酯(TG)≥1.7mmol/L(150mg/ dl),这是对一般人群而言的,近年来,强调根据危险水平决定干预起始与目标值,可以认为,超过上述标准时,即可视为相对高脂血症。
Hyperlipidemia, which is a combination of hypercholesterolemia and hypertriglyceridaemia, refers to the pathological state when the blood lipid level exceeds the upper limit of the reference value. At this point, the patient does not have any clinical symptoms, often with cardiovascular and peripheral arterial sclerosis as the outcome, with serious consequences, often referred to as “silent killer ”. The recommended standards for domestic hyperlipidemia are: total cholesterol (TC) ≥5.76mmol / L (220mg / dl), low density lipoprotein cholesterol (LDL-C) ≥3.64mmol / L HDL ≤1.04mmol / L (40 mg / dl), triglyceride (TG) ≥1.7mmol / L (150mg / dl), which is for the general population, in recent years, emphasizing that according to the risk The level of intervention to determine the starting and target value, can be considered, beyond the above criteria, can be considered as relatively hyperlipidemia.